Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Community-acquired pneumonia hospital admission decision

Introduction

Overview

Overview

The initial step of the management plan of a patient with community acquired pneumonia is the decision on hospital admission (inpatient vs. outpatient treatment). If the patient is to be admitted to the hospital, a decision should be made as to whether there should be an admission to the general medical floor or to the intensive care unit (ICU).

Hospital Admission Decision

Hospital Admission Decision

Patients with high-risk community-acquired pneumonia should be admitted to the hospital for treatment. Severity of illness scores, such as CURB 65 and Pneumonia Severity Index (PSI), are used to stratify patients.

Admission to the hospital is warranted in the following cases:[1]

  • CURB 65 β‰₯2, OR
  • High PSI score: There is no cut-off value for the PSI score; a higher score is associated with a higher risk of morbidity and mortality. A Risk Class I pneumonia patient can be sent home on oral antibiotics. A Risk Class II-III pneumonia patient may be sent home with IV antibiotics or treated and monitored for 24 hours in hospital. Patients with Risk Class IV-V pneumonia patient should be hospitalized for treatment.
ICU Admission Decision

ICU Admission Decision

Patients with severe community-acquired pneumonia should be admitted to the ICU if any of the following is present:[1]

  • Invasive mechanical ventilation (major criteria), OR
References

References

  1. ↑ 1.0 1.1 Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG (2007). “Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults”. Clinical Infectious DiseasesΒ : an Official Publication of the Infectious Diseases Society of America. 44 Suppl 2: S27–72. doi:10.1086/511159. PMIDΒ 17278083. Retrieved 2012-09-06. Unknown parameter |month= ignored (help)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]